Health Conditions Related to Genetic Changes
Atypical hemolytic-uremic syndrome
MedlinePlus Genetics provides information about Atypical hemolytic-uremic syndrome
More About This Health ConditionC3 glomerulopathy
At least one mutation in the C3 gene has been found to cause a rare form of kidney disease called C3 glomerulopathy. This disorder damages the kidneys and can lead to end-stage renal disease (ESRD), a life-threatening condition that prevents the kidneys from filtering fluids and waste products from the body effectively.
The identified C3 gene mutation deletes two amino acids from the C3 protein. This genetic change is described as a "gain-of-function" mutation because it leads to an altered version of the protein that overactivates the complement system. The overactive system damages structures in the kidneys called glomeruli, which are clusters of tiny blood vessels that help filter waste products from the blood. Damage to glomeruli prevents the kidneys from filtering waste products normally and can lead to ESRD.
Several other changes in the C3 gene do not cause C3 glomerulopathy directly but appear to increase the likelihood of developing the disorder. In particular, the C3F allotype is seen more frequently in people with this condition than in the general population. Researchers are working to determine how the C3F allotype may influence disease risk.
More About This Health ConditionAge-related macular degeneration
MedlinePlus Genetics provides information about Age-related macular degeneration
More About This Health ConditionOther disorders
At least 17 mutations in the C3 gene have been found to cause C3 deficiency, a rare condition characterized by recurrent bacterial infections beginning in childhood. The genetic changes that cause C3 deficiency lead to an altered version of the C3 protein or prevent cells from producing any of this protein. These mutations are described as "loss-of-function" because the abnormal or missing C3 protein prevents normal activation of the complement system. As a result, the immune system is less able to protect the body against foreign invaders (such as bacteria).
Other Names for This Gene
- acylation-stimulating protein cleavage product
- AHUS5
- ARMD9
- ASP
- C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1
- C3a
- C3b
- CO3_HUMAN
- complement component 3
- CPAMD1
Additional Information & Resources
Tests Listed in the Genetic Testing Registry
Scientific Articles on PubMed
Catalog of Genes and Diseases from OMIM
References
- Martinez-Barricarte R, Heurich M, Valdes-Canedo F, Vazquez-Martul E, Torreira E, Montes T, Tortajada A, Pinto S, Lopez-Trascasa M, Morgan BP, Llorca O, Harris CL, Rodriguez de Cordoba S. Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation. J Clin Invest. 2010 Oct;120(10):3702-12. doi: 10.1172/JCI43343. Epub 2010 Sep 13. Citation on PubMed or Free article on PubMed Central
- Okura Y, Kobayashi I, Yamada M, Sasaki S, Yamada Y, Kamioka I, Kanai R, Takahashi Y, Ariga T. Clinical characteristics and genotype-phenotype correlations in C3 deficiency. J Allergy Clin Immunol. 2016 Feb;137(2):640-644.e1. doi: 10.1016/j.jaci.2015.08.017. Epub 2015 Oct 4. No abstract available. Citation on PubMed
- Xiao X, Pickering MC, Smith RJ. C3 glomerulopathy: the genetic and clinical findings in dense deposit disease and C3 glomerulonephritis. Semin Thromb Hemost. 2014 Jun;40(4):465-71. doi: 10.1055/s-0034-1376334. Epub 2014 May 5. Citation on PubMed
- Zipfel PF, Skerka C, Chen Q, Wiech T, Goodship T, Johnson S, Fremeaux-Bacchi V, Nester C, de Cordoba SR, Noris M, Pickering M, Smith R. The role of complement in C3 glomerulopathy. Mol Immunol. 2015 Sep;67(1):21-30. doi: 10.1016/j.molimm.2015.03.012. Epub 2015 Apr 28. Citation on PubMed
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.